| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Developmental Origins of Health and Disease Research Division (M.C.R., I.T.C., R.S., A.V., L.S., S.C., C.D.B.), Institute of Developmental Sciences, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, United Kingdom; and Wessex Fertility Unit (S.I., C.D.S.), Southampton SO15 5QS, United Kingdom
Address all correspondence and requests for reprints to: Dr. Malcolm C. Richardson, Institute of Developmental Sciences, Mailpoint 887, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, United Kingdom. E-mail: mcr2{at}soton.ac.uk.
Context: Production of 3-carbon units (as lactate) by granulosa cells (GCs) is important in follicular and oocyte development and may be modulated by metformin.
Objective: The aim of the study was to examine the action of metformin on GC lactate production and potential mediation via AMP-activated protein kinase (AMPK).
Design: GCs were prepared from follicular aspirates. After exposure to metformin and other potential modulators of AMPK in culture, aspects of cellular function were examined.
Setting: The study was conducted in a private fertility clinic/university academic center.
Patients: Women undergoing routine in vitro fertilization participated in the study.
Interventions: All agents were added in culture.
Main Outcome Measures: Lactate output of GCs was measured. Cell extracts were prepared after culture, and phosphorylated forms of AMPK and acetyl CoA carboxylase (ACC) were assayed using Western analysis.
Results: Metformin led to a rapid increase in lactate production by GCs [minimum effective dose, 250 µM; maximum dose studied, 1 mM (1.22-fold; P < 0.01)]. This dose range of metformin was similar to that required for stimulation of phospho-AMPK in GCs [minimum effective dose, 250 µM; maximum effect, 500 µM (2.01-fold; P < 0.001)]. Increasing phospho-ACC, as a representative downstream target regulated by AMPK, was apparent over a lower range (minimum effective dose, 31 µM; maximum effect, 250 µM; P < 0.001). A level of metformin (125 µM) insufficient for the stimulation of lactate output when used alone potentiated the effects of suboptimal doses of insulin on lactate production. Adiponectin (2.5 µg/ml) had a small but significant effect on lactate output.
Conclusions: Metformin activates AMPK in GCs, stimulating lactate production and increasing phospho-ACC. Metformin also enhances the action of suboptimal insulin concentrations to stimulate lactate production.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |